+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type (Blood Culture), By Technology (PCR, ISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899563
Description Jump to:
The global bloodstream infection testing market size is expected to reach USD 977.57 million by 2030, registering at a CAGR of 4.5% The increasing number of infectious diseases globally and the growing awareness and emphasis on infection control are some of the major factors driving the market. For Instance, according to an epidemiologic survey organized by the European Centre for Disease Prevention and Control (ECDC) in April 2022, there was a notable increase in Candida auris cases across the European region. The survey revealed a significant rise in reported cases of C. auris, from 335 cases reported by 8 countries in 2020 to 655 cases reported by 13 countries in 2021. Bloodstream infections accounted for 15.3% of the reported cases in 2021.

In addition, increasing technological advancements and new product launches by key companies in the market, encouraging government initiatives, and increasing awareness about the importance of blood donation are expected to propel market growth. For instance, in April 2020. DNAe, a next-generation sequencing company, has received a 'Breakthrough Device' designation from the U.S. Food and Drug Administration (FDA) for its innovative LiDia-SEQ platform and first assay. This designation enables DNAe to develop rapid and cost-effective tests for infectious disease diagnostics, cancer, infection control, and pandemic preparedness and response. The designated assay focuses on infectious diseases, specifically bloodstream infections (BSI) and antimicrobial resistance (AMR), aiming to detect and identify infections associated with sepsis directly from patient specimens. Through the Breakthrough Device program, the FDA will provide ongoing support and collaborative interactions to facilitate the development and launch of DNAe's LiDia-SEQ sequencing system and BSI/AMR test.

The key players in the market, such as F. Hoffmann-La Roche Ltd., bioMérieux SA, BD, etc., are implementing the strategy of merger & acquisition to enhance product capabilities and promote their product offerings. For instance, in May 2021, F. Hoffmann-La Roche Ltd. completed the acquisition of GenMark Diagnostics for USD 1.8 billion. This acquisition would help Roche expand its molecular diagnostics portfolio. Similarly, in December 2021, the company acquired TIB Molbiol Group, which has around 45 CE-IVD-approved assays for hematology testing, inherited genetic testing, diagnosing infectious diseases, and transplant medicine.

Bloodstream Infection Testing Market Report Highlights

  • Based on the product, the reagents and consumables segment accounted for the largest revenue share of the market in 2022. The segment is also expected to grow at the fastest rate over the forecast period owing to the easy availability and frequent purchase of screening products for donors and recipients
  • Based on sample type, the blood culture segment accounted for the largest revenue share in 2022 and is expected to witness the fastest CAGR over the forecast period
  • Based on technology, the PCR segment held the largest revenue share of the market in 2022 and is expected to grow with the fastest CAGR over the forecast period owing to increasing demand for the tests
  • Based on end-user, the hospital and diagnostic centers segment accounted for the largest revenue share in 2022
  • North America dominated the bloodstream infection testing market and accounted for the largest revenue share in 2022. This is due to the region's Increasing disposable income, highly developed health infrastructure, and favorable reimbursement policies


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Sample Type segment
1.1.1.2. Product segment
1.1.1.3. Technology segment
1.1.1.4. End-use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product and Sample Type Snapshot
2.3. Technology and End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of infectious diseases
3.2.1.2. Technological advancements in bloodstream infection testing
3.2.1.3. Growing initiatives for blood donations campaign
3.2.2. Market Restraint Analysis
3.2.2.1. High diagnosis cost and lower investments in underdeveloped countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Bloodstream Infection Testing Market: Product Business Analysis
4.1. Bloodstream Infection Testing Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Reagents and Consumables
4.3.1. Reagents and Consumables Market, 2018 - 2030 (USD Million)
Chapter 5. Bloodstream Infection Testing Market: Sample Type Business Analysis
5.1. Bloodstream Infection Testing Market: Sample Type Movement Analysis
5.2. Whole Blood
5.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
5.3. Blood Culture
5.3.1. Blood Culture Market, 2018 - 2030 (USD Million)
Chapter 6. Bloodstream Infection Testing Market: Technology Business Analysis
6.1. Bloodstream Infection Testing Market: Technology Movement Analysis
6.2. PCR
6.2.1. PCR Market, 2018 - 2030 (USD Million)
6.3. Mass Spectroscopy
6.3.1. Mass Spectroscopy Market, 2018 - 2030 (USD Million)
6.4. In Situ Hybridization
6.4.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Bloodstream Infection Testing Market: End-User Business Analysis
7.1. Bloodstream Infection Testing Market: End-User Movement Analysis
7.2. Hospitals & Diagnostic Centers
7.2.1. Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
7.3. Custom Laboratory Service Providers
7.3.1. Custom Laboratory Service Providers Market, 2018 - 2030 (USD Million)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Bloodstream Infection Testing Market: Regional Business Analysis
8.1. Bloodstream Infection Testing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. U.S. Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.4.6. Canada Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.2.6. UK Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. Germany Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. France Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. Italy Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Spain Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Denmark Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Sweden Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Norway Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.2.6. Japan Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. China Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. India Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. Australia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. Thailand Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. South Korea Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.2.6. Brazil Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Mexico Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Scenario
8.5.4.6. Argentina Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Scenario
8.6.2.6. South Africa Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. Saudi Arabia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. UAE Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. Kuwait Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
Chapter 9. Bloodstream Infection Testing Market: Competitive Landscape
8.1. Participant Categorization
9.1.1. bioMérieux SA
9.1.1.1. Overview
9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. BD
9.1.2.1. Overview
9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Cepheid
9.1.3.1. Overview
9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Seegene Inc.
9.1.4.1. Overview
9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. T2 Biosystems, Inc.
9.1.5.1. Overview
9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. F. Hoffmann-La Roche Ltd
9.1.6.1. Overview
9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Siemens Healthcare Limited
9.1.7.1. Overview
9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Luminex Corporation
9.1.8.1. Overview
9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. Bruker
9.1.9.1. Overview
9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. Accelerate Diagnostics, Inc.
9.1.10.1. Overview
9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives
9.2. Participant’s Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Company Market Share Analysis, 2022
9.6. Strategy Mapping
9.6.1. Expansion
9.6.2. Acquisition
9.6.3. Product/Service Launch
9.6.4. Others
Chapter 10. Analyst View
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Bloodstream Infection Testing Market, By Product, 2018-2030 (USD Million)
Table 4 Global Bloodstream Infection Testing Market, By Sample type, 2018-2030 (USD Million)
Table 5 Global Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 6 Global Bloodstream Infection Testing Market, By End-user, 2018-2030 (USD Million)
Table 7 Global Bloodstream Infection Testing Market, By Region, 2018-2030 (USD Million)
Table 8 North America Bloodstream Infection Testing Market, By Country, 2018-2030 (USD Million)
Table 9 North America Bloodstream Infection Testing Market, By Product, 2018-2030 (USD Million)
Table 10 North America Bloodstream Infection Testing Market, By Sample type, 2018-2030 (USD Million)
Table 11 North America Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 12 North America Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 13 U.S. Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 14 U.S. Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 15 U.S. Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 16 U.S. Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 17 Canada Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 18 Canada Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 19 Canada Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 20 Canada Bloodstream Infection Testing market, by End-use, 2018-2030 (USD million)
Table 21 Europe Bloodstream Infection Testing market, by Country, 2018-2030 (USD Million)
Table 22 Europe Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 23 Europe Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 24 Europe Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 25 Europe Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 26 UK Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 27 UK. Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 28 UK Bloodstream Infection Testing Market, By Technology, 2018-2030 (USD Million)
Table 29 UK Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 30 Germany Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 31 Germany Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 32 Germany Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 33 Germany Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 34 France Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 35 France Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 36 France Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 37 France Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 38 Italy Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 39 Italy Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 40 Italy Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 41 Italy Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 42 Spain Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 43 Spain Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 44 Spain Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 45 Spain Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 46 Denmark Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 47 Denmark Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 48 Denmark Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 49 Denmark Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 50 Sweden Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 51 Sweden Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 52 Sweden Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 53 Sweden Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 54 Norway Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 55 Norway Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 56 Norway Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 57 Norway Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 58 Asia Pacific Bloodstream Infection Testing market, by Country, 2018-2030 (USD Million)
Table 59 Asia Pacific Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 60 Asia Pacific Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 61 Asia Pacific Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 62 Asia Pacific Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 63 Japan Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 64 Japan Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 65 Japan Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 66 Japan Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 67 China Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 68 China Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 69 China Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 70 China Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 71 India Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 72 India Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 73 India Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 74 India Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 75 Australia Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 76 Australia Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 77 Australia Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 78 Australia Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 79 Thailand Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 80 Thailand Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 81 Thailand Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 82 Thailand Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 83 South Korea Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 84 South Korea Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 85 South Korea Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 86 South Korea Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 87 Latin America Bloodstream Infection Testing market, by Country, 2018-2030 (USD Million)
Table 88 Latin America Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 89 Latin America Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 90 Latin America Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 91 Latin America Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 92 Brazil Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 93 Brazil Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 94 Brazil Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 95 Brazil Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 96 Mexico Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 97 Mexico Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 98 Mexico Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 99 Mexico Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 100 Argentina Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 101 Argentina Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 102 Argentina Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 103 Argentina Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 104 Middle East & Africa Bloodstream Infection Testing market, by Country, 2018-2030 (USD Million)
Table 105 Middle East & Africa Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 106 Middle East & Africa Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 107 Middle East & Africa Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 108 Middle East & Africa Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 109 South Africa Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 110 South Africa Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 111 South Africa Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 112 South Africa Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 113 Saudi Arabia Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 114 Saudi Arabia Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 115 Saudi Arabia Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 116 Saudi Arabia Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 117 UAE Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 118 UAE Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 119 UAE Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 120 UAE Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
Table 121 Kuwait Bloodstream Infection Testing market, by Product, 2018-2030 (USD Million)
Table 122 Kuwait Bloodstream Infection Testing market, by Sample type, 2018-2030 (USD Million)
Table 123 Kuwait Bloodstream Infection Testing market, by Technology, 2018-2030 (USD Million)
Table 124 Kuwait Bloodstream Infection Testing market, by End-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Microscope software, market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT analysis
Fig. 14 Porter’s five forces analysis
Fig. 15 Global bloodstream infection testing market: product movement & market share analysis.
Fig. 16 Global bloodstream infection testing market, for reagents and consumables, 2018-2030 (USD Million)
Fig. 17 Global bloodstream infection testing market, for instruments, 2018-2030 (USD Million)
Fig. 18 Global bloodstream infection testing market: Sample type movement & market share analysis.
Fig. 19 Global bloodstream infection testing market, for whole blood, 2018-2030 (USD Million)
Fig. 20 Global bloodstream infection testing market, for blood culture, 2018-2030 (USD Million)
Fig. 21 Global bloodstream infection testing market: Technology movement & market share analysis.
Fig. 22 Global bloodstream infection testing market, for PCR, 2018-2030 (USD Million)
Fig. 23 Global bloodstream infection testing market, for mass spectroscopy, 2018-2030 (USD Million)
Fig. 24 Global bloodstream infection testing market, for in situ hybridization, 2018-2030 (USD Million)
Fig. 25 Global bloodstream infection testing market, for others, 2018-2030 (USD Million)
Fig. 26 Global bloodstream infection testing market: End-use movement & market share analysis.
Fig. 27 Global bloodstream infection testing market, for end-use, movement & market share analysis.
Fig. 28 Global bloodstream infection testing market, for hospitals & diagnostic centers, 2018-2030 (USD Million)
Fig. 29 Global bloodstream infection testing market, for custom laboratory service providers, 2018-2030 (USD Million)
Fig. 30 Global bloodstream infection testing market, for academic & research institutes, 2018-2030 (USD Million)
Fig. 31 Global bloodstream infection testing market, for others, 2018-2030 (USD Million)
Fig. 32 Regional marketplace: key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 Global bloodstream infection testing market: region movement analysis.
Fig. 35 North America bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 36 U.S. key country dynamics
Fig. 37 U.S. bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 38 Canada key country dynamics
Fig. 39 Canada bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 40 Europe bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 41 UK key country dynamics
Fig. 42 UK bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 43 Germany key country dynamics
Fig. 44 Germany bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 45 France key country dynamics
Fig. 46 France bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 47 Italy key country dynamics
Fig. 48 Italy bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 49 Spain key country dynamics
Fig. 50 Spain bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 51 Denmark key country dynamics
Fig. 52 Denmark bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 53 Sweden key country dynamics
Fig. 54 Sweden bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 55 Norway key country dynamics
Fig. 56 Norway bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 57 Asia Pacific bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 58 Japan key country dynamics
Fig. 59 Japan bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 60 China key country dynamics
Fig. 61 China bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 62 India key country dynamics
Fig. 63 India bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 64 Australia key country dynamics
Fig. 65 Australia bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 66 Thailand key country dynamics
Fig. 67 Thailand bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 68 South Korea key country dynamics
Fig. 69 South Korea bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 70 Latin America bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 71 Brazil key country dynamics
Fig. 72 Brazil bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 73 Mexico key country dynamics
Fig. 74 Mexico bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 75 Argentina key country dynamics
Fig. 76 Argentina bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 77 Middle East and Africa bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 78 South Africa key country dynamics
Fig. 79 South Africa bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 80 Saudi Arabia key country dynamics
Fig. 81 Saudi Arabia bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 82 UAE key country dynamics
Fig. 83 UAE bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 84 Kuwait key country dynamics
Fig. 85 Kuwait bloodstream infection testing market, 2018-2030 (USD Million)
Fig. 86 Company market position analysis
Fig. 87 Company/competition categorization
Fig. 88 Strategy mapping

Companies Mentioned

  • bioMérieux SA
  • BD
  • Cepheid
  • Seegene Inc.
  • T2 Biosystems, Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare Limited
  • Luminex Corporation
  • Bruker
  • Accelerate Diagnostics, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 689.13 Million
Forecasted Market Value ( USD ) by 2030 $ 977.57 Million
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bloodstream Infection Testing - Global Strategic Business Report - Product Image

Bloodstream Infection Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 113 Pages
  • Global
From
North America Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type, By Technology, By End-user, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

North America Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type, By Technology, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • North America
From
Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032 - Product Image

Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Hospital Acquired Infection Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Hospital Acquired Infection Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From

About the Bloodstream Infection Test Market

The Bloodstream Infection Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of bacteria, fungi, and viruses in the bloodstream. The test is typically performed on a sample of blood taken from a patient, and the results are used to diagnose and treat infections. The test can also be used to monitor the effectiveness of treatments. The Bloodstream Infection Test market is highly competitive, with a range of products available from different manufacturers. These products vary in terms of accuracy, cost, and turnaround time. The market is also subject to regulatory requirements, which can affect the availability of certain products. Some companies in the Bloodstream Infection Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.